Introducing pentavalent vaccine in the EPI in India: A counsel for caution

Indian Journal of Medical Research

Volumn 132, Issue 7, 2010, Pages 1-3

  Lone, Zubair ^a   Puliyel, Jacob M ^a  

^a ST STEPHEN S HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE VACCINE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE; VACCINE;

ASIA; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG INDUSTRY; EDITORIAL; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS MENINGITIS; HEALTH PROGRAM; HUMAN; INDIA; MORTALITY; PNEUMONIA; WORLD HEALTH ORGANIZATION; BACTERIAL MEMBRANE; LEGAL ASPECT; MASS IMMUNIZATION; STANDARD;

BACTERIAL CAPSULES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; INDIA; MASS VACCINATION; MENINGITIS, HAEMOPHILUS; VACCINES, COMBINED;

EID: 77954434827     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Editorial

References (27)

1. Delamothe T. H1N1: now entering the recrimination phase. BMJ 2010; 340: c225.
2. Watson R. Politician accuses drug companies of overplaying dangers of H1N1. BMJ 2010; 340: c198.
3. Kant L. NTAGI subcommittee recommendations on Haemophilus infuenzae type B (Hib) vaccine introduction in India. Indian Pediatr 2009; 46: 945-54.
4. UNICEF. Pneumonia the forgotten killer of children. Available at: http://www.unicef.org/publications/fles/Pneumonia_The_Forgotten_Killer_of_Children.pdf, accessed on January 24, 2010.
5. World Health Organization. WHO position paper on Haemophilus infuenzae type b conjugate vaccines. Wkly Epidemiol Rec 2006; 81: 445-52.
6. Lau YL. Haemophilus infuenzae type b disease in Asia. Bull World Health Organ 1999; 77: 867-8.
7. Puliyel JM, Mathew JL, Priya R. Incomplete reporting of research in press releases: Ettu, WHO. Indian J Med Res 2010; 131: 588-9.
8. Watt JP, Levine OS, Santosham M. Global reduction of Hib disease: What are the next steps? Proceedings of the meeting Scottsdale, Arizona. J Pediatr 2003; 143: S163-87.
9. Murphy TV, Osterholm MT, Pierson LM, White KE, Breedlove JA, Seibert GB, et al. Prospective surveillance of Haemophilus infuenzae type b disease in Dallas County, Texas, and in Minnesota. Pediatrics 1987; 79: 173-80.
10. Levine OS, Benjamin S, Nathanial P, Mark K. Development, evaluation and implementation of Haemophilus infuenza type b vaccines for young children in developing countries: current status and priority actions. Pediatr Infect Dis J 1998; 17 (9 Suppl): S95-113.
11. Lau YL, Yung R, Low L, Sung R, Leung CW, Lee WH. Haemophilus infuenzae type b infections in Hong Kong. Pediatr Infect Dis J 1998; 17 (Suppl. 9): S165-9.
12. Puliyel JM, Agarwal KS, Abed Abass F. Natural immunity to Haemophilus infuenzae b in infancy in Indian children. Vaccine 2001; 19: 4592-4.
13. Minz S, Balraj V, Lalitha MK, Murali N, Cherian T, Manoharan G, et al. Incidence of Haemophilus infuenzae type b meningitis in India. Indian J Med Res 2008; 128: 57-64.
14. Gellert GA, Wenger JD, Brilla A. Haemophilus infuenzae type b disease in Latvia. Lancet 1994; 344: 959.
15. Invasive Bacterial Infections Surveillance (IBIS) Group of the International Clinical Epidemiology Network. Are Haemophilus infuenzae infections a signifcant problem in India? A prospective study and review. Clin Infect Dis 2002; 34: 949-57.
16. Cherian T, Thomas N, Raghupathy P, Durot I, Dutta A. Safety and immunogenicity of Haemophilus infuenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age: author reply. Indian Pediatr 2002; 39: 1070-71.
17. The Hib initiative. Hib initiative research and surveillance activities. Available at: http://www.hibaction.org/research.php#vaccine_probe, accessed on January 23, 2010.
18. Gessner BD, Sutanto A, Linehan M, Djelantik IG, Fletcher T, Gerudug IK, et al. Incidences of vaccine-preventable Haemophilus infuenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet 2005; 365: 43-52.
19. Baqui AH, EI Arifeen S, Saha SK, Persson L, Zaman K, Gessner BD, Moulton LH, Black RE, Santosham M. Effectiveness of Haemophilus infuenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladesh children: a case control study. Pediatr Infect Dis J 2007; 26: 565-71.
20. Wikipedia. Post-hoc analysis. Available at: http://en.wikipedia.org/wiki/Post-hoc_analysis, accessed on January 25, 2010.
21. Tsang RS, Sill ML, Skinner SJ, Law DK, Zhou J, Wylie J. Characterization of invasive Haemophilus infuenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin Infect Dis 2007; 44: 1611-4.
22. Brown VM, Madden S, Kelly L, Jamieson FB, Tsang RSW, Ulanova M. Invasive Haemophilus infuenzae disease caused by non-type b strains in Northwestern Ontario, Canada, 2002-2008. Clin Infect Dis 2009; 49: 1240-3.
23. Bar-On ES, Goldberg E, Fraser A, Vidal L, Hellmann S, Leibovici L. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus infuenzae B (HIB). Cochrane Database Systematic Rev 2009, Issue 3. Art. No.: CD005530.
24. Adult A. Combination DPT/Hib vaccine fails FDA test. Lancet 1997; 349: 1752.
25. WHO. Expert Panel Report. Report of a WHO ad hoc expert panel to review reports of serious AEFI following administration of pentavalent and other vaccines-Sri Lanka, 23 December 2008.
26. Chaturvedi S. Vaccines as tools to reduce ARI burden: Merits and some inherent verticality in the debate. Indian Pediatr 2010; 47: 34-7.
27. Pelden S. Pentavalent vaccine suspended. Kuensel Online 28 October 2009. Available at: http://www.kuenselonline. com/modules.php?name=news&fle=article&sid=13826, accessed on January 24, 2010.